Mutual of America Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Mutual of America Capital Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.27M	Sell	67,825 -3,310	-5%	-$211K	0.04%	490
2026 Q1	$4.99M	Sell	71,135 -43,325	-38%	-$3.03M	0.06%	396
2025 Q4	$9.37M	Sell	114,460 -7,881	-6%	-$588K	0.1%	200
2025 Q3	$7.27M	Sell	122,341 -10,637	-8%	-$524K	0.08%	285
2025 Q2	$5.39M	Buy	132,978 +2,689	+2%	+$121K	0.06%	402
2025 Q1	$6.69M	Buy	130,289 +192	+0.1%	+$9.49K	0.08%	287
2024 Q4	$7.2M	Sell	130,097 -357	-0.3%	-$16.2K	0.08%	291
2024 Q3	$4.29M	Buy	+130,454	New	+$3.67M	0.05%	543

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mutual of America Capital Management's TARS Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 4.7% in Q2 2026, selling an estimated $211K and leaving 67,825 shares worth $4.27M. The position accounts for 0.04% of the portfolio, ranked #490.

Mutual of America Capital Management first reported a position in TARS in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.37M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Mutual of America Capital Management held 67,825 shares of Tarsus Pharmaceuticals worth $4.27M as of Q2 2026.
Mutual of America Capital Management sold 3,310 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $211K.
Tarsus Pharmaceuticals made up 0.04% of Mutual of America Capital Management's portfolio in Q2 2026, its #490 holding.
Mutual of America Capital Management first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
Mutual of America Capital Management's Tarsus Pharmaceuticals position peaked at $9.37M in Q4 2025.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.